Didier Menard
Overview
Explore the profile of Didier Menard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
234
Citations
9197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wade A, Sene S, Caspar E, Diallo F, Platon L, Thiebaut L, et al.
J Antimicrob Chemother
. 2025 Jan;
80(3):828-839.
PMID: 39846779
Background: Since 2006, artemisinin-based combination therapies (ACTs) have been introduced in Senegal in response to chloroquine resistance (CQ-R) and have shown high efficacy against Plasmodium falciparum. However, the detection of...
2.
Proellochs N, Andolina C, Ramjith J, Stoter R, van Gemert G, Graumans W, et al.
bioRxiv
. 2025 Jan;
PMID: 39763803
The emergence of parasites partially resistant to artemisinins (ART-R) poses a significant threat to recent gains in malaria control. ART-R has been associated with PfKelch13 (K13) mutations, which differ in...
3.
Rakotoarisoa M, Rakotomanga T, Fenomanana J, Musango L, Raobela O, Salava J, et al.
Am J Trop Med Hyg
. 2024 Dec;
112(3):610-619.
PMID: 39689361
Malaria remains a significant public health concern in Madagascar. The WHO recommends using parasitological methods to confirm Plasmodium infection before treatment. This study evaluated the performance of two rapid diagnostic...
4.
Teou D, Dorkenoo A, Ataba E, Yakpa K, Sossou E, Ma L, et al.
Am J Trop Med Hyg
. 2024 Sep;
111(5):977-983.
PMID: 39288769
In areas where malaria is endemic and microscopes are unavailable, rapid diagnostic tests (RDTs) are essential tools for early diagnosis and prompt and effective treatment. However, HRP2-based RDTs are threatened...
5.
Lu F, Xu J, Liu Y, Ren Z, Chen J, Gong W, et al.
PLoS Pathog
. 2024 Jun;
20(6):e1012334.
PMID: 38941356
Plasmodium vivax serological exposure markers (SEMs) have emerged as promising tools for the actionable surveillance and implementation of targeted interventions to accelerate malaria elimination. To determine the dynamic profiles of...
6.
Ishengoma D, Gosling R, Martinez-Vega R, Beshir K, Bailey J, Chimumbwa J, et al.
Nat Med
. 2024 May;
30(7):1807-1808.
PMID: 38710833
No abstract available.
7.
Dorkenoo A, Warsame M, Ataba E, Hemou M, Yakpa K, Sossou E, et al.
Malar J
. 2024 Apr;
23(1):92.
PMID: 38570791
Background: Artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) are the currently recommended first- and second-line therapies for uncomplicated Plasmodium falciparum infections in Togo. This study assessed the efficacy of these combinations, the...
8.
Abebe A, Dieng C, Dugassa S, Abera D, Shenkutie T, Assefa A, et al.
Malar J
. 2024 Feb;
23(1):55.
PMID: 38395885
Background: Plasmodium vivax Duffy binding protein (PvDBP) is a merozoite surface protein located in the micronemes of P. vivax. The invasion of human reticulocytes by P. vivax merozoites depends on...
9.
Platon L, Leroy D, Fidock D, Menard D
Microbiol Spectr
. 2024 Feb;
12(4):e0350023.
PMID: 38363132
During blood-stage infection, parasites are constantly exposed to a range of extracellular stimuli, including host molecules and drugs such as artemisinin derivatives, the mainstay of artemisinin-based combination therapies currently used...
10.
Menard D, Mihreteab S, Fidock D
N Engl J Med
. 2023 Dec;
389(26):2497-2498.
PMID: 38157513
No abstract available.